CSPC Pharmaceutical Group マネジメント
マネジメント 基準チェック /24
CSPC Pharmaceutical Groupの CEO はCuilong Zhangで、 May2022年に任命され、 の在任期間は 2.5年です。 の年間総報酬はCN¥ 13.47Mで、 5.1%給与と94.9%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の0.043%を直接所有しており、その価値はHK$ 25.65M 。経営陣と取締役会の平均在任期間はそれぞれ2.5年と7.7年です。
主要情報
Cuilong Zhang
最高経営責任者
CN¥13.5m
報酬総額
| CEO給与比率 | 5.1% |
| CEO在任期間 | 2.5yrs |
| CEOの所有権 | 0.04% |
| 経営陣の平均在職期間 | 2.5yrs |
| 取締役会の平均在任期間 | 7.7yrs |
経営陣の近況
Recent updates
Is CSPC Pharmaceutical Group Limited (HKG:1093) Trading At A 48% Discount?
Nov 15
Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Oct 16Earnings Not Telling The Story For CSPC Pharmaceutical Group Limited (HKG:1093) After Shares Rise 26%
Sep 30CSPC Pharmaceutical Group Limited (HKG:1093) Investors Are Less Pessimistic Than Expected
Aug 08Here's Why CSPC Pharmaceutical Group (HKG:1093) Can Manage Its Debt Responsibly
Jun 17CSPC Pharmaceutical Group Limited Just Recorded A 20% Revenue Beat: Here's What Analysts Think
May 29CSPC Pharmaceutical Group (HKG:1093) Has Announced A Dividend Of CN¥0.14
May 21CSPC Pharmaceutical Group (HKG:1093) Will Pay A Dividend Of CN¥0.14
Apr 29There's Reason For Concern Over CSPC Pharmaceutical Group Limited's (HKG:1093) Price
Apr 22CSPC Pharmaceutical Group's (HKG:1093) Dividend Will Be CN¥0.14
Apr 01CSPC Pharmaceutical Group Limited (HKG:1093) Shares Could Be 49% Below Their Intrinsic Value Estimate
Jan 22Some Confidence Is Lacking In CSPC Pharmaceutical Group Limited's (HKG:1093) P/E
Jan 04Are Investors Undervaluing CSPC Pharmaceutical Group Limited (HKG:1093) By 36%?
Oct 22Is CSPC Pharmaceutical Group (HKG:1093) A Risky Investment?
Sep 21CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 62% Above Its Share Price
Jul 09Does CSPC Pharmaceutical Group (HKG:1093) Have A Healthy Balance Sheet?
Jun 20CSPC Pharmaceutical Group's (HKG:1093) Shareholders Will Receive A Bigger Dividend Than Last Year
Jun 01CSPC Pharmaceutical Group (HKG:1093) Is Increasing Its Dividend To CN¥0.11
Apr 04CSPC Pharmaceutical Group Limited's (HKG:1093) Intrinsic Value Is Potentially 92% Above Its Share Price
Mar 12CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | CN¥5b |
| Jun 30 2024 | n/a | n/a | CN¥6b |
| Mar 31 2024 | n/a | n/a | CN¥6b |
| Dec 31 2023 | CN¥13m | CN¥693k | CN¥6b |
| Sep 30 2023 | n/a | n/a | CN¥6b |
| Jun 30 2023 | n/a | n/a | CN¥6b |
| Mar 31 2023 | n/a | n/a | CN¥6b |
| Dec 31 2022 | CN¥11m | CN¥693k | CN¥6b |
| Sep 30 2022 | n/a | n/a | CN¥6b |
| Jun 30 2022 | n/a | n/a | CN¥6b |
| Mar 31 2022 | n/a | n/a | CN¥6b |
| Dec 31 2021 | CN¥9m | CN¥693k | CN¥6b |
| Sep 30 2021 | n/a | n/a | CN¥6b |
| Jun 30 2021 | n/a | n/a | CN¥6b |
| Mar 31 2021 | n/a | n/a | CN¥5b |
| Dec 31 2020 | CN¥9m | CN¥693k | CN¥5b |
| Sep 30 2020 | n/a | n/a | CN¥4b |
| Jun 30 2020 | n/a | n/a | CN¥4b |
| Mar 31 2020 | n/a | n/a | CN¥4b |
| Dec 31 2019 | CN¥7m | CN¥693k | CN¥4b |
| Sep 30 2019 | n/a | n/a | CN¥4b |
| Jun 30 2019 | n/a | n/a | CN¥3b |
| Mar 31 2019 | n/a | n/a | CN¥3b |
| Dec 31 2018 | CN¥4m | CN¥298k | CN¥3b |
報酬と市場: Cuilongの 総報酬 ($USD 1.86M ) は、 Hong Kong市場 ($USD 735.87K ) の同規模の企業の平均を上回っています。
報酬と収益: Cuilongの報酬は 20% 以上増加しましたが、会社の収益は過去 1 年間で 20% 以上減少しました。
CEO（最高経営責任者
Cuilong Zhang (55 yo)
2.5yrs
在職期間
CN¥13,472,000
報酬
Mr. Cuilong Zhang has been the Vice Chairman of CSPC Pharmaceutical Group Ltd since May 21, 2019 and serves as its Chief Executive Officer since May 27, 2022. He was Rotating Chief Executive Officer of CSP...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 27.6yrs | CN¥26.68m | 24.16% HK$ 14.4b | |
| Vice-Chairman & CEO | 2.5yrs | CN¥13.47m | 0.043% HK$ 25.6m | |
| Executive Director & Chief Scientist | 6.9yrs | CN¥9.42m | 0.039% HK$ 23.1m | |
| Executive Director | no data | CN¥4.92m | 0.013% HK$ 7.7m | |
| Executive Director | no data | CN¥5.74m | 0.013% HK$ 7.7m | |
| Executive Director | no data | CN¥4.90m | 0.013% HK$ 7.7m | |
| Executive Director | no data | CN¥4.02m | 0.026% HK$ 15.4m | |
| Group Executive President | no data | データなし | データなし | |
| Executive Director | less than a year | データなし | データなし | |
| Executive president & President of Global Research and Development | less than a year | データなし | データなし | |
| Company Secretary | 3.8yrs | データなし | データなし |
2.5yrs
平均在職期間
54.5yo
平均年齢
経験豊富な経営陣: 1093の経営陣は 経験豊富 であると考えられます ( 2.5年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Executive Chairman | 27.6yrs | CN¥26.68m | 24.16% HK$ 14.4b | |
| Vice-Chairman & CEO | 6.3yrs | CN¥13.47m | 0.043% HK$ 25.6m | |
| Executive Director & Chief Scientist | 6.9yrs | CN¥9.42m | 0.039% HK$ 23.1m | |
| Executive Director | 18.1yrs | CN¥4.92m | 0.013% HK$ 7.7m | |
| Executive Director | 14.1yrs | CN¥5.74m | 0.013% HK$ 7.7m | |
| Executive Director | 12.8yrs | CN¥4.90m | 0.013% HK$ 7.7m | |
| Executive Director | 4yrs | CN¥4.02m | 0.026% HK$ 15.4m | |
| Group Executive President | less than a year | データなし | データなし | |
| Executive Director | less than a year | データなし | データなし | |
| Independent Non-Executive Director | 3.8yrs | CN¥340.00k | データなし | |
| Independent Non-Executive Director | 11.9yrs | CN¥142.00k | データなし | |
| Independent Non-Executive Director | 8.4yrs | CN¥142.00k | データなし |
7.7yrs
平均在職期間
54.5yo
平均年齢
経験豊富なボード: 1093の 取締役会 は 経験豊富 であると考えられます ( 7.7年の平均在任期間)。